Picture This — FDA Taking Inspection Photos

Law360, New York (August 22, 2013, 9:25 PM EDT) -- In a draft guidance document issued recently, the U.S. Food and Drug Administration identified four nonexclusive categories of prohibited behavior that the agency considers to constitute “delaying, denying, limiting or refusing a drug inspection.” In particular, the new guidance expands the FDA’s power to photograph during inspections and characterizes attempts to limit photography as a prohibited behavior.

Section 707 of the Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. 112-144, provides the FDA discretion to deem any drug adulterated that was “manufactured, processed,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.